Latest filing published 13 Jul 2018 for Oncopeptides AB, €19k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elisabet Augustsson: trading record in brief
All filings by Elisabet Augustsson on record concern Oncopeptides AB. Over a trading history stretching from 22 February 2017 to 13 July 2018, the count stands at 2 filings.
Both buying and selling appear: 1 purchase worth €4,862, against 1 sale worth €19k. Netting one side against the other leaves €14k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2018 alone, the filings show no purchases and 1 sale.
The newest entry dates from 13 July 2018: an open-market sale of €19k, in Oncopeptides AB. The most recent open-market purchase was published on 22 February 2017, 3,547 days ago. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elisabet Augustsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ SEK 200.00ISIN SE0009414576FI:csv-0a6406d5a093f7377ae0
- 1,000 shares@ SEK 46.00ISIN SE0009414576FI:csv-cd9146b799ce60ed7210Canonical exit: 23 May 2017 (T+90)
2 of 2 declarations